 InPharm |
Pipeline Progresses at Glaxo/THRX – Analyst Blog
NASDAQ The companies also completed the phase III Breo registrational program for the treatment of persistent asthma in adults and adolescents. Positive results were reported from a study evaluating the efficacy and safety of fluticasone furoate and … GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with … GSK, Theravance seek approvals for FF/VI in US, Europe GSK and Theravance file COPD drug |
View full post on asthma – Google News